Group One Trading’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-55,569
Closed -$415K 9266
2025
Q3
$173K Buy
55,569
+17,788
+47% +$47.1K ﹤0.01% 4824
2025
Q2
$80.9K Buy
37,781
+29,665
+366% +$47.9K ﹤0.01% 5158
2025
Q1
$9.33K Sell
8,116
-26,733
-77% -$45.9K ﹤0.01% 6305
2024
Q4
$76.3K Buy
34,849
+24,733
+244% +$56K ﹤0.01% 4744
2024
Q3
$22.1K Sell
10,116
-31,495
-76% -$72.4K ﹤0.01% 5176
2024
Q2
$96.1K Sell
41,611
-21,757
-34% -$90.4K ﹤0.01% 3997
2024
Q1
$349K Sell
63,368
-259,581
-80% -$1.19M ﹤0.01% 3076
2023
Q4
$798K Buy
+322,949
New +$3.07M ﹤0.01% 2676

Other funds holding VTYX

Group One Trading's VTYX Position: Q4 2025 in Review

Group One Trading sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 55,569 shares — an estimated $415K sold.

Group One Trading first reported a position in VTYX in Q4 2023 and held it in 8 quarters. The position peaked at $798K in Q4 2023. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Group One Trading reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 55,569 Ventyx Biosciences shares in Q4 2025, an estimated $415K.
  • Group One Trading first reported a position in Ventyx Biosciences in Q4 2023 and held it in 8 quarters.
  • Group One Trading's Ventyx Biosciences position peaked at $798K in Q4 2023.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.